Big bucks for brains! New York AI startup Hebbia just landed a cool $130 million in Series B funding, a war chest to revolutionize how businesses find information. Tech titans Andreessen Horowitz and Index Ventures led the round, with heavy hitters like Peter Thiel and Google’s venture arm joining the party. This investment spree signifies…
In a stride forward for the fintech industry, Lithuanian startup FreeBnk has secured $3 million in combined equity and token funding to bolster its cutting-edge cryptocurrency investment app. This funding round was led by prominent investors including Founderheads, ChaiTech Ventures, LVT Capital, and Lavender Capital, signifying robust confidence in FreeBnk’s vision and capabilities. Founded with…
In a significant development for the future of computing, German quantum computing company planqc has secured €50 million in a Series A funding round. This substantial investment, led by the European Family Office CATRON Holding and the DeepTech & Climate Fonds (DTCF), propels planqc to the forefront of the global race to develop fault-tolerant quantum…
Zhiyi Biotech, a pioneering clinical-stage biotech specializing in live biotherapeutic products (LBPs), has achieved significant milestones with its latest clinical trial results for SK10. The Phase I study, conducted in the United States, has demonstrated promising outcomes in the treatment of chemotherapy-induced diarrhea (CID) using SK10, an innovative heat-killed Bacteroides fragilis product. The randomized, double-blind,…
QED Protocol, a pioneering force in the realm of Web3 development leveraging Bitcoin’s capabilities, has announced a successful $6 million funding round led by Blockchain Capital. This investment is set to propel QED’s groundbreaking technology, which promises to redefine the landscape of smart contracts, layer-two solutions, and various Web3 applications. QED Protocol stands at the…
In a significant win for environmental awareness, Natcap, a pioneering nature intelligence company, has secured $10 million in an oversubscribed Series A funding round. This impressive feat, achieved amidst a challenging global fundraising environment, underscores the growing recognition of nature’s critical role in business strategy. The funding round, led by prominent figures like André Hoffmann…
Iktos, a pioneering leader in AI and Robotics for drug design, has announced its acquisition of Synsight, a renowned French biotech company specializing in AI-driven drug discovery targeting protein-protein (PPI) and RNA-protein (RPI) interactions. This strategic merger bolsters Iktos’ comprehensive AI-based drug discovery platform, integrating Synsight’s advanced technology to enhance biological testing capabilities crucial for…
A new wave of hope is washing over the oncology field with Myricx Bio’s impressive £90 million ($114 million) Series A funding. This UK biotech company, unlike its peers, isn’t taking an incremental step forward. Instead, they’re wielding a whole new weapon in the fight against cancer: N-Myristoyltransferase inhibitor (NMTi) antibody-drug conjugates (ADCs). The significance…
Longform.ai, a dynamic UvA spin-off at the forefront of AI innovation, has announced a significant milestone in its journey towards transforming audio data analytics. The company has secured €300K from Innovatiefonds Noord-Holland to propel its subscription-based AI service aimed at extracting actionable insights from vast troves of audio content. As online conversations in podcasts and…
Coimbra, Portugal-based Eneida has secured €10.5 million in a Series B funding round led by Junction Growth Investors, marking a significant milestone in enhancing its Neighbourhood Grid Intelligence platform for Zero Emission Neighbourhoods (ZEN). The funding round also saw participation from Santander Alternative Investments, Korys, HCapital, and the company’s founders, underscoring broad support for Eneida’s…
